Manresana de Micobacteriologia, SL   Report issue

For profit
Founded: Barcelona Spain (2013)
Status: No NME R&D (2013)

Organization Overview

First Clinical Trial
2014
NCT02076139
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2015

Timeline

NOW
  • Now

Active Ingredients

Drugs in Other Trials (1)

nyaditum resae (2 trials)

Indications

Overview

  • Highest Phase: Phase 0
  • # of Trials: 2
  • # of Trial APIs: 1